Guelph company developing life-saving drugs from tobacco plants

PlantForm Corporation, a University of Guelph spin-off company, is working to secure funding for more trials of its innovative treatments to combat critical illnesses like cancer.

The principle focus of PlantForm’s work is using tobacco plants to create low-cost versions of biosimilar drugs – plant-based, generic versions of biological medications.

The plants are grown indoors and, through genetic engineering, made to express certain compounds that are then purified into alternatives to popular drugs like Herceptin, used to treat breast cancer.

“We are now in the final stages of securing a third round of funding that will let us take our best drug candidates forward into animal studies,” explains Don Stewart, PlantForm’s President and CEO. “We’ve demonstrated efficacy in an animal model, and that’s key to us moving forward with trying to secure funding for clinical trials.”

Typical biologic medications are manufactured using highly expensive mammalian-cell culture systems in...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.aginnovationontario.ca/en/guelph-company-developing-life-saving-drugs-from-plants/#more-275